Jezerskyte, E.
van Berge Henegouwen, M. I.
van Laarhoven, H. W. M.
van Kleef, J. J.
Eshuis, W. J.
Heisterkamp, J.
Hartgrink, H. H.
Rosman, C.
van Hillegersberg, R.
Hulshof, M. C. C. M.
Sprangers, M. A. G.
Gisbertz, S. S.
,
Article History
Received: 17 December 2020
Accepted: 29 April 2021
First Online: 25 May 2021
Disclosure
: M. I. van Berge Henegouwen has a consultant role with Mylan, Johnson and Johnson, and Medtronic, as well as research funding from Olympus and Stryker. H. W. M. van Laarhoven has a consultant or advisory role with BMS, Lilly, MSD, Merck, Nordic Pharma, Servier, as well as research funding from Bayer, BMS, Celgene, Janssen, Lilly, Merck, Nordic Pharma, Philips, Roche, and Servier. C. Rosman has research funding from Johnson & Johnson and Medtronic. R. van Hillegersberg is a proctor for Intuitive Surgery. The remaining authors have no conflicts of interest.